Mark Blaxill, Executive Director
Mark Blaxill is co-founder and Executive Director of XLP Capital, a firm founded in 2015 and focused on technology strategy development, new technology business incubation and technology-based investments. Before starting XLP, Mr. Blaxill was a co-Founder and Managing Partner of 3LP Advisors, a firm focused on IP strategy development, patent transactions and IP-based investments. Previous to launching the launch of 3LP in 2008, he was a 25-year veteran of the Boston Consulting Group, where as senior vice president and partner, he headed the firm's Strategy Practice and recruited BCG’s core IP Strategy team. In this role, he launched the firm's Intellectual Property practice, developed proprietary tools for technology analysis, and co-authored BCG's first patent application.
He is the co-author of The Invisible Edge: Taking Your Strategy to the Next Level Using Intellectual Property (Portfolio, 2009), which was named Best Strategy Book in 2009 by a leading business journal. He has been named one of “The World’s Leading IP Strategists” by IAM Magazine. Mark credits that honor to the unique integration (developed over a decade and a half at BCG, 3LP and XLP) of the quantitative analyses of technology, patents, business and financial performance. One of his clients said something that made him proud: “a lot of companies can analyze your business and technology strategy. But what [you] can do, that’s a thing of beauty.”
Mr. Blaxill earned an M.B.A. with distinction from Harvard Business School and an A.B. from Princeton University's Woodrow Wilson School of Public and International Affairs, where he graduated summa cum laude and Phi Beta Kappa. None of this is especially important, but he did work very hard to succeed when he was younger.
Mark has two children, including a daughter diagnosed with autism and has been prominently involved in autism advocacy work, including efforts to quantify time trends in autism and chronic childhood illness and to assess the impact of a range of environmental factors. He writes often on autism, science and public policy issues and has published a number of articles, letters and commentaries on autism in scientific journals. He has testified before the Immunization Safety Review of the Institute of Medicine (2001), served on a Blue Ribbon Panel on Vaccine Safety (2004), initiated a symposium sponsored by the National Institute of Environmental Health Sciences entitled “Environmental Factors in Neurodevelopmental Disorders” (2005) and a workshop sponsored by the Institute of Medicine entitled “Autism and the Environment: Challenges and Opportunities for Research” (2007). He was a panelist at a “Meeting on Evaluating Reasons for ASD Trends” co-sponsored by the Centers for Disease Control and Autism Speaks (2011) and at a hearing “1 in 88 Children: A Look Into the Federal Response to Rising Rates of Autism” called by the House of Representatives’ Oversight and Government Reform Committee (2012). Recently divorced, he now divides his time between New York, Boston and Minneapolis.